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Abstract
Background: Sexually transmitted infections (STIs) represent signifi-
cant risk factors for HIV transmission and adverse fetal complications 
in pregnancy. We tested 240 pregnant women for their HIV serostatus 
and for the effects of HIV-STI coinfections on CD4+ cell counts and 
on HIV plasma viral load. The study was conducted at four antenatal 
clinics in Akure, Ondo State of Nigeria between November 2014 and 
December 2015. 
Methods: The HIV-1/2 strip was used for preliminary determination 
of HIV serostatus and this was followed by a confirmatory Abbott 
enzyme-linked immunosorbent assay (ELISA) procedure. CD4+ T-cell 
counts were done by cytometric analysis while viral load was determi-
ned by COBAS® AmpliPrep TaqMan HIV-1 procedure. Liver enzymes 
were determined by an automated chemistry analyzer. Detection of 
hepatitis B virus (HBV), hepatitis C virus (HCV), human papilloma virus-6 
(HPV-6) and herpes simplex virus type-2 (HSV-2) were determined by 
ELISA. The syphilis VDRL test was done by the rapid plasma reagin 
procedure, while Trichomonas vaginalis infection was demonstrated 
by the wet mount procedure. Infections with Chlamydia trachomatis 
and Neisseria gonorrhoeae were determined respectively by ELISA and 
by culture on proteose peptone agar supplemented with 5% serum. 
Results: The results show prevalence of STIs in 33.3% of the 240 
study participants; 77.5% for HIV seropositive and 22.5% for serone-
gative subjects. Trichomonas vaginalis constituted the highest isolate 
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Introduction
Studies have shown that sexually transmitted di-
seases (STDs) such as Neisseria gonorrhea, Tricho-
monas vaginalis, Chlamydia trachomatis, human 
herpes simplex-2 (HSV-2) and human papilloma 
virus-6 (HPV-6) are significant risk factors for HIV 
transmission in women [1]. HIV infection in preg-
nant women may lead to adverse fetal outcomes, 
while co-infection of HIV with any STI during preg-
nancy may accelerate the development of fetal and 
maternal complications [2]. A recent study from 
Nigeria reported that infection with Trichomonas 
vaginalis increased the risk of HIV infection, whi-
le another study showed an HIV infection rate of 
33% among women with infections of T. vaginalis. 
Studies from Zimbabwe reported that women with 
a history of genital ulcers and pelvic inflamma-
tory disease were six times more likely to contract 
HIV than normal individuals [3]. Another study 
showed that improved STD treatment in a rando-
mized controlled trial in Tanzania reduced the rate 
of new HIV infections, underscoring the role of 
STIs in HIV susceptibility. Epidemiological studies 
from sub-Saharan Africa, Europe and North Ame-
rica have suggested that there is approximately a 
four-times greater risk of becoming infected with 
HIV in the presence of a genital ulcer such as those 
caused by syphilis and chancroid [4]. Prevalenc e 
rates of syphilis as high as 30% have been des-
cribed in antenatal women while 4.2% of women 
in a population-based study in Tanzania reported 
a history of genital ulcers [5]. Such co-infections 
may significantly increase HIV plasma viral load [6]. 
It was estimated that a 10-fold increase of plas-
ma HIV RNA resulted in an 81% increased rate 
of HIV transmission [7, 8]. About 350-400 million 
people worldwide are chronically infected with 
HBV, with over a million individuals dying annually 
from HBV related complications [2]. HIV and HBV 
are two viruses with similar modes of transmission 
through sexual contact, mother-to- child transmis-
sion (MTCT) in pregnancy, breast-feeding and in-
travenous drug use [2]. While HIV and HBV have 
common modes of transmission, HBV has been 
shown to be about 100 times more infectious [8]. 
Our study investigated the frequency of HIV-STI 
coinfections and their effects on CD4+ cell count, 
HIV plasma viral load and liver enzyme elevations 
in 50% of HIV seropositive subjects and 22.2% for seronegative con-
trols. HIV-HBV coinfection occurred among 7 individuals while HIV-
HBV-TV coinfection occurred in 4 individuals. The results also showed 
elevated titers of alanine aminotransferase (ALT), creatinine and total 
bilirubin liver enzymes in both HIV-HBV coinfection and HBV mono-
infection. HIV viral loads were twice as high in HIV-HBV coinfection 
relative to HBV mono- infection.
Conclusion: The prevalence of STIs was significantly high at 54.4% 
among HIV seropositive pregnant women as compared to 14.3% for 
HIV seronegative pregnant women. T. vaginalis was the highest isolate 
at 50% in HIV seropositive subjects and may therefore be a driving 
factor for HIV transmission and susceptibility as very few T. vaginalis 
infections were recorded in control subjects.
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among HIV seropositive women who attended an-
tenatal clinics at Akure in Ondo State of Nigeria. It 
is expected that the findings from our study would 
enable clinicians to better manage HIV coinfections 
in both pregnant and non-pregnant women so as 
to reduce complications that pose a risk for fetal 
mortality and maternal morbidity. 
Methods
Study centers
This prospective study was conducted from Nov-
ember 2014 to December 2015 at four antenatal 
health care centers at Akure in Ondo State, Nige-
ria. The study included 240 participants, with 114 
HIV seropositive and 126 seronegative women in 
their third trimester of pregnancy. The mean ages 
for the seropositive and seronegative women were 
31.81 and 29.05 years respectively. Approval for 
the study was obtained from the Ondo State Hos-
pital Management and Ethics committee, while in-
formed consent was received from all participants 
following questionnaire responses and examination 
of case files managed by the attending physicians. 
Inclusion Criteria 
Informed consent, pregnancy in the third trimester 
and participation in the highly active antiretroviral 
therapy (HAART) were criteria for inclusion in the 
study. There was no age restriction for participation, 
as all subjects were required to keep all physician 
appointments throughout the study. 
HIV screening 
Blood was collected by venupuncture from each 
participant. A measured small aliquot was applied 
onto the HIV-1/2 strip (Determine Test, Alere, UK) 
for preliminary determination of HIV serostatus. 
Confirmatory test for HIV infection was performed 
using an ELISA procedure (Abbott Laboratories, Chi-
cago, IL, USA). 
Immunological Assessment 
CD4+ cell counts were carried out by standard 
cytometric procedure following manufacturer’s ins-
tructions (CyFlow SL-3, Partec, Germany®), and with 
the establishment of a baseline cell count [10]. The 
counts were repeated at 3 and 6 months later. 
Viral load measurement
Serum aliquots from the whole blood collection 
were also used for the HIV viral load assessment. 
Serum was separated from whole blood by centri-
fugation at room temperature within 6 hours of 
blood collection, aliquoted, and frozen at -70oC un-
til processing for viral load measurement. The viral 
load (plasma HIV RNA copies) which quantifies the 
viral burden of HIV in the blood was assayed only in 
HIV seropositive subjects. The COBAS® AmpliPrep 
TaqMan HIV-1 Qual test (version 3.2 series 3.3) kit 
was employed for the assay [11].
Sexually transmitted infections (STIs) 
Some sexually transmitted infections (STIs) among 
the study participants were determined using sera 
from both HIV infected and HIV non-infected preg-
nant women. Only clear non- haemolysed specimens 
were used. Specimens were brought to room tem-
perature after being thawed. An automated che-
mistry analyser (Vitros 350) was employed for deter-
mination of liver enzymes following manufacturer’s 
instructions. A modified ELISA method was used 
for detection of hepatitis B virus (HBV), hepatitis 
C virus (HCV), human papilloma virus-6 (HPV-6) 
and herpes simplex virus type-2 (HSV-2). A positive 
HBV infection was indicated by the demonstration 
of hepatitis B virus surface antigen (HBsAg). In this 
procedure, two drops of plasma were transferred 
to the cassettes containing coated antigen (Abon 
Biopharm (Hangzhou) Co. Ltd, Hangzhou, China). 
Thereafter, a drop of buffer (reagents A and B) was 
added to the cassettes and the assay was timed for 
10 -20 minutes and visually observed for a forma-
tion of two red colored bands as an indication of 
a positive test. The rapid plasma reagin test (VDRL) 
InternatIonal archIves of MedIcIne 
sectIon: InfectIous dIseases
ISSN: 1755-7682
2016
Vol. 9 No. 200
doi: 10.3823/2071
This article is available at: www.intarchmed.com and www.medbrary.com 4
was used for the detection of infection with Trepo-
nema pallidum, the causative agent of syphilis. T. 
vaginalis was detected by preparing a wet smear 
on a clean grease-free slide with a drop of sterile 
normal saline and high vaginal fluid sample collec-
ted from the subjects. Each participant presenting 
with T. vaginalis was initially examined for clinical 
symptoms of yellow discharge, abnormal vaginal 
odour, vulval itching and signs of colpitis macularis 
(‘‘strawberry cervix’’) purulent vaginal discharge and 
vulvar erythema. While sensitivity of symptoms and 
signs is relatively low, nonetheless, clinical manifes-
tations are routinely used to identify patients for 
whom wet mount examination would likely have 
low yield. Subsequently, the wet mount slide was 
examined under the microscope for highly motile 
tiny spear shaped flagellates with an axostyle. This 
slide examination was performed within 10 to 20 
min of sample collection. 
The presence of Chlamydia trachomatis in high 
vaginal swab sample was determined by an enzy-
me immunosorbent assay (EIA) using cervical mucus 
obtained from the vaginal posterior fornix of each 
subject. Each sample was introduced into a casset-
te containing coated antigen, rinsed by buffer (rea-
gents A and B), processed according to the instruc-
tions of the manufacturer (ABON, Abon Biopharm 
(Hangzhou) Co., Ltd., Hangzhou, China) and visually 
observed also for a formation of two colored bands 
as an indication of a positive test. 
Similarly, high vaginal swab was collected from 
the posterior fornix from each pregnant subject by 
the attending physician using sterile bivalve specu-
lum (Changzhou Huankang Medical Devices Co. 
Ltd, Changzhou City, China) and sterile cotton-tip-
ped applicator (Evepon Industrial Limited, Onitsha, 
Anambra, Nigeria) into freshly prepared sterile thio-
glycollate medium and incubated at 37oC for 24 
h for growth. Thereafter a loopful of the sample 
was streaked onto freshly prepared agar plates (pro-
teose peptone agar supplemented with 5% serum) 
for isolation of N. gonorrhoeae. The organism was 
identified by sugar fermentation test that included 
glucose, maltose, sucrose and lactose. Only gram 
negative diplococci isolates with bean-shaped colo-
nies that were also positive for glucose fermentation 
were confirmed as N. gonorrhoeae.
Statistical Analysis of Data
Statistical evaluation was done using student t- test 
and one- way analysis of variance (ANOVA) with p 
≤ 0.05 as a measure of statistical significance. SPSS 
(Chicago, IL, SPSS Inc., 2007) version 17.0 for Win-
dows® was used to perform the analysis.
Results
Tables 1 and 2 show the distribution of sexually 
transmitted infections (STIs) among HIV seropositive 
and seronegative pregnant women in the study po-
Table 1.  Profile of sexually transmitted infections in relation to age among HIV seropositive pregnant wo-
men.
Age Range
No of  Subjects 
With STIs
TV HBV HCV HSV-2 HPV-6 VDRL
Chlamydia 
trachomatis
Neisseria 
gonorrhoeae 
<19 0 - - - - - - - -
20-25 3 1 - - 2 - - - -
26-31 20 11 3 - 2 - 3 1 -
32-37 32 16 2 - 1 5 2 1 5
38-43 7 3 2 - - 1 1 - -
Total 62 31 7 - 5 6 6 2 5
TV: Trichomonas vaginalis, HBV: hepatitis B virus, HCV: hepatitis C virus, HSV: herpes simplex virus type 2, HPV: human papilloma virus-6, 
VDRL: veneral disease research laboratory-Syphilis, Chlamydia trachomatis, Neisseria gonorrhoeae
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pulation. Diagnostic tests showed that 62 (54.4%) 
of the 114 seropositive women were positive for 
STIs, compared to 18 (14.3%) of the seronegative 
women. The vaginal wet mount procedure was used 
to demonstrated the presence of T. vaginalis infec-
tion in 31 (50%) of the 62 HIV seropositive women 
who had STIs, compared to four (22.2%) of the 18 
seronegative women with STIs. Our ELISA procedu-
re also revealed HBV infection in seven (11.3%) and 
HSV-2 infection in five (8.0%) as well as HPV-6 in 
six (9.7%) of the seropositive women. On the other 
hand, the results in Table 2 show that the numbers 
and the overall percentages of seronegative women 
who had HBV, HSV-2, HPV-6, N. gonorrhoeae and 
syphilis were significantly lower than in those who 
were HIV seropositive. Among the seronegative 
pregnant women with STIs, 16.6% had HBV, only 
one had HSV-2 infection and two had HPV-6 infec-
tions. Proteose peptone agar and sugar fermenta-
tion cultures revealed N. gonorrhoeae infection in 
five (8.0%) of the seropositive pregnant women. 
The VDRL test demonstrated T. pallidum syphilis in-
fection also in six (9.7%) of the seropositive women. 
Only two (3.2%) of the seropositive women were 
positive for Chlamydia trachomatis infection. On the 
other hand, only two of the seronegative women 
had N. gonorrhoeae infection while another two 
were positive for the syphilis test. HCV infection 
was not detected in any of the study participants. 
Tables 1 and 2 also show the distribution of STIs 
among various age groups of the study population. 
There was no association between age groups and 
prevalence of STIs. Table 3 shows the differences 
between the prenatal and postnatal CD4+ and HIV 
viral loads among the various age groups of HIV 
seropositive pregnant women. The results show a 
range of 373 to 475 for the CD4+ cells/mm3 for the 
HIV seropositive pregnant women, a range that is 
significantly lower than those for the seronegative 
pregnant women. Also the lowest CD4+ cell count 
of 378 cells/mm3 and the highest HIV viral load 
of 19,742 RNA copies/mL were found in the 32-
37 year age group, showing a correlation between 
high viral load and low CD4+ cell numbers. In the 
Table 2.  Profile of sexually transmitted infections in relation to age among HIV seronegative pregnant 
women.
Age Range
No of  Subjects 
With STIs
TV HBV HCV HSV-2 HPV-6 VDRL
Chlamydia 
trachomatis
Neisseria 
gonorrhoeae 
<19 1 - - - - 1 - - -
20-25 5 1 1 - 1 1 - 1 -
26-31 7 3 1 - - - 1 1 1
32-37 4 - 0 - - - 1 2 1
38-43 1 - 1 - - - 0 0 0
Total 18 4 3 - 1 2 2 4 2
TV: Trichomonas vaginalis, HBV: hepatitis B virus, HCV: hepatitis C virus, HSV: herpes simplex virus type 2, HPV: human papilloma virus-6, 
VDRL: veneral disease research laboratory-Syphilis, Chlamydia trachomatis, Neisseria gonorrhoeae
Table 3.  Prenatal and postnatal CD4+ cell counts 
and HIV viral load in HIV seropositive preg-
nant women.
Prenatal Postnatal
Age 
group
No. 
CD4+ 
Counts
 HIV viral 
load
CD4+ 
counts
HIV viral 
load  
yrs cells/mm3 
RNA 
copies/mL 
cells/mm3 
RNA 
copies/mL
20-25 9 427 4.313 383 3.270 
26-31 36  438 3.987 401 4.373 
32-37 57  378 19.742 626 2.460
38-43 12 475 3.280 419 3.351 
Mean 
counts 
429 7.830 457 3.363 70.05
Negative 
Controls
750 - - - 76.19
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postnatal period, the highest CD4+ count of 626 
cells/mm3 and the lowest HIV viral load were also 
recorded among the 32-37 year age group, indi-
cating an improvement in the health status of the 
women in that age group after child delivery. The 
results did not show any correlation between age 
and viral load, nor with CD4 cell counts among the 
HIV seropositive women. We did additional analysis 
with the seven pregnant women who had HIV/HBV 
coinfection. The results of their CD4+ cell counts, 
HIV viral loads, liver enzymes of alanine aminotrans-
ferase (ALT), creatinine and bilirubin are presented 
in Table 4. The results show that the mean CD4+ 
cells in normal seronegative pregnant women was 
750 cells/mm3, 781 cells/mm3 for women with HBV 
monoinfection, 429-457 cells/mm3 for HIV monoin-
fected women and 327-387 cells/mm3 for prenatal 
and postnatal HIV-HBV coinfected women. These 
results show the CD4+ adverse reducing effect of 
HBV infection in HIV seropositive women. Table 4 
also shows that the mean prenatal and postnatal 
plasma HIV viral loads for the HIV-HBV coinfected 
women were respectively 8,787 and 4,705 RNA co-
pies/mL, which were significantly much higher than 
the 7,830 and 3,363 RNA copies/mL for the HIV 
mono-infected women. These numbers again show 
a correlation between increased HIV viral load and 
lower CD4+ cell counts. The results also show that 
the prenatal mean titers of ALT (59 IU/L), creatinine 
(43mg/dL) and bilirubin (11mg/dL) and also the post-
natal titers of HIV-HBV coinfected women were 10 
-20 times higher than those of normal seronegative 
women. These increases in the liver enzyme titers 
reflect the deleterious inflammatory effect of HBV 
co-infection in HIV seropositive women. 
Discussion
The study investigated the prevalence of coinfection 
of HIV with selected sexually transmitted infections 
as well as their effects on the CD4 + cell counts, 
plasma HIV viral loads, and liver enzymes among 
114 HIV seropositive pregnant women at antena-
tal clinics in Akure, Ondo State between November 
2014 and December 2015. HIV seronegative preg-
nant women in the third trimester of pregnancy 
served as controls. The study revealed the remarka-
ble effect of STI co-infections in the prognosis of 
HIV infection among HIV seropositive pregnant 
women. Sixty two (54.4%) of the HIV seropositive 
pregnant women had a co-infection of one or more 
STI, compared to 18 (14.3%) of HIV seronegative 
pregnant women. Interestingly, 31 (50%) of the 
62 HIV seropositive pregnant women with STI co-
infections had a co-infection of T. vaginalis, while 
five to seven co-infected women had a co-infection 
with HBV, HSV-2, HPV-6, T. pallidum and N. go-
norrhoeae. These observations would suggest and 
that STIs, particularly T. vaginalis, may constitute a 
significant risk factor for HIV susceptibility in wo-
men. The preponderance of T. vaginalis infection 
among HIV seropositives is particularly interesting 
in many instances [12], as other studies have noted 
that T. vaginalis infection may expand the portal of 
entry for HIV in exposed individuals, thus facilita-
ting HIV transmission and increasing HIV shedding 
[13, 14]. Investigators have reported that wet mount 
procedure that is often used for T. vaginalis scree-
ning seems to have a low sensitivity of about 70%. 
Nonetheless, clinical symptoms have been used to 
supplement the diagnosis of infected patients [15]. 
Findings from this and other studies suggest that T. 
Table 4.  Prenatal and postnatal CD4+ counts, HIV 
viral load and liver enzymes in HIV-HBV 
co-infected pregnant and normal control 
women.
Normal 
Control
HBV 
alone
HIV-HBV
Pre-Postnatal 
CD4+ cells (cells/mm3 750 781 327-387 
HIV load 
(RNA copies/mL)
- - 8.787-4.705
ALT enzyme (IU/L) 19 22 59-75 
Creatinine (mg/dL) 0.5-1 50 43-50
Bilirubin (mg/dL) 1.5 7 11-35 
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vaginalis and HIV may predispose one to another 
and vice versa [14]. Given the current availability of 
antiretroviral drugs in developing countries and the 
contribution of T. vaginalis infection on HIV trans-
mission, it is evident that appropriate and prompt 
treatment of T. vaginalis infection would be essen-
tial to reducing the incidence of HIV infection [14].
Some studies have reported that HBV and HIV 
coinfection may not play a significant role in HIV 
disease progression [16] but that antiretroviral the-
rapy may increase the risk of hepatotoxicity when 
starting HIV therapy [17] and also elevating the risk 
of hepatic flares when active treatment for both 
HIV and HBV is disrupted [18]. The effects of HIV 
coinfection with HBV on CD4 cell counts, HIV vi-
ral load and liver enzymes were also evaluated in 
our study. While the ALT value in normal individuals 
is ≤ 19 IU/L for women, the value was however 
elevated in HIV-HBV coinfection. ALT is a marker 
of liver inflammation or other hepatocyte damage. 
However, it has been shown that normal ALT levels 
can also be associated with liver disease progres-
sion, particularly in HBeAg negative and HIV coin-
fected patients. Our results show that the mean 
CD4+ T cell counts and plasma viral loads among 
the 7 individuals both at antenatal and post natal 
periods were significantly different. We also noted 
abnormal high titers of ALT of 59 -75 IU/L, creati-
nine at 43-50mg/dL and total bilirubin of 11-35mg/
dL at both antenatal and postnatal periods. These 
high values in Table 4 are indicative of progressive 
liver damage [19, 20, 21]. Analysis of the profile of 
the four others with three HIV-HBV-TV coinfections 
showed a mean CD4+ T cell count of 314.75 cells/
mm3 compared to 405.3 cells/mm3 for three indi-
viduals with only HIV-HBV coinfection. The mean 
viral load of the women with three coinfections was 
4,375.5 RNA copies/mL, compared to 1,255 RNA 
copies/mL for the HIV-HBV coinfected individuals, 
thus representing a threefold decrease. The results 
of this study suggest that HIV coinfection with T. va-
ginalis may amplify and facilitate HIV infection. Our 
study is important in that it comprehensively eva-
luated the effect of STIs in HIV progression among 
HIV seropositive women in the third trimester of 
their pregnancy. The pathological complications to 
mother and fetus that may result from HIV-STI coin-
fections may result in multiple organ damage and 
lead to severe development fetal complications as 
well maternal morbidity and mortality. 
Conclusion
In conclusion, our study showed the high prevalen-
ce of STIs among HIV seropositive pregnant wo-
men, with about a four-fold increase (54.4%) over 
the 14.3% prevalence among the HIV seronegative 
controls. The study also revealed that T. vaginalis 
was the predominant STI among the HIV-STI coin-
fected seropositive group (50%) as compared to the 
22.2% among the HIV seronegative mothers. The 
study compared the mean CD4+ cell count, plas-
ma viral load and liver enzymes among selected 7 
individuals with HIV-HBV coinfection and showed 
that the mean CD4+T cell and plasma viral load at 
antenatal period was 327cells/mm3 and 8,787 RNA 
copies/mL respectively while mean CD4+T cell cou-
nt and plasma viral load at postnatal period were 
337.25 cells/mm3 and 4,705 RNA copies/mL Simi-
larly, results from the liver enzymes (ALT, creatinine, 
total bilirubin) also revealed no significant difference 
in values in both the antenatal and postnatal period 
among the subjects [17, 18]. 
Limitation of the Study:
The sensitivity of the techniques employed may have 
posed some limitation in the study. The detection 
of T. vaginalis by wet mount, syphilis by non trepo-
nemal rapid plasma reagin and C. trachomatis may 
have lowered sensitivity values. We are nonetheless, 
aware of sensitive techniques such as nucleic acid 
test (NAT) for gonorrhoea as well as immunofluo-
rescence for DNA amplification for C. trachomatis 
both of which are often not available in resource 
constraint centers.
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